Manage Your Liver
Q:

An entirely new risk group for liver cancer is found

An entirely new risk group for liver cancer is found
A:

For years we have known that there is a strong link between obesity and liver cancer, and it is possibly due to the high fat content in the body. And because of this, people with obesity are often considered at risk for liver cancer. A recent research conducted by Monash University and the Peter MacCallum Cancer Centre in Australia confirms that obese people are at risk for liver cancer, but based on an entirely different reason.

 

The new finding

The research uncovers that liver cancer can develop in obese people without having the progression of NASH or cirrhosis.

The common course of liver cancer progression would normally be from non-alcoholic fatty liver disease (NAFLD) to NASH, cirrhosis, and then liver cancer. But the research revealed that liver cancer in people with obesity does not seem to be reliant on the development of NASH or cirrhosis.

That means liver diseases in obese people can directly go from NAFLD to liver cancer without showing any signs or symptoms.

In the research, it was revealed that the proteins that drive the progression of liver cancer in the obesity-NASH-cirrhosis pathway are different from the proteins that drive the development of liver cancer without NASH or cirrhosis in people with obesity.

 

The dangerous implication behind

In the current American and European surveillance programs for Hepatocellular carcinoma (HCC), the most common type of liver cancer, regular monitoring of HCC is only given to individuals with cirrhosis. Even though obesity is a risk factor for liver cancer, obese patients without cirrhosis are not considered as a priority because of the presumed course of liver cancer progression.

With the new discovery, it means that a group of people with a potentially high risk for liver cancer are not receiving the necessary screenings that they should have. That is to say, obese patients might develop liver cancer without any prior warnings.

 

What can we do?

We must first understand that fatty liver disease and NASH are silent diseases, meaning that they often show few or no symptoms before a very late stage.

Given the lack of screening programs for liver cancer for people who do not have cirrhosis, people with obesity should be aware of their liver condition and maintain their liver in good shape as early as possible. Reducing liver fat content and inflammation level and also good management of diabetes can help stop the progression of NAFLD. Patients should bear in mind that liver problems at the early stage are highly treatable.

Most important of all, losing weight and eating a healthy diet are the best ways to manage the situation for people with obesity.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Recently we have received a number of inquiries about the treatment options for fatty liver. After being diagnosed with fatty liver disease, patients are often left with frustration, not sure what they can do to fix this problem. Like in many cases, doctors are unable to offer any clear treatment options apart from diet and exercise.   Why don’t doctors offer any treatment plans? Though fatty liver is common, currently there is still
A:
Fatty liver disease is often found in people with obesity or diabetes. However, people who appear healthy and have a normal weight might also have this problem – have you ever wondered why? Someone could live a healthy lifestyle and don't have any obvious risk factors for NAFLD, but could still have an elevated ALT level (commonly a first indicator of fatty liver disease). Why is it the case? Recent research discovered that our genes are to be blamed.  
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.